Join
Live feed
·
INSIDERFilingvia Quantisnow
Atara Biotherapeutics Inc. logo

Chief Accounting Officer Grant-Huerta Yanina sold $15,000 worth of shares (2,218 units at $6.76), decreasing direct ownership by 6% to 37,067 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ATRA (Atara Biotherapeutics Inc.) and more on Quantisnow.